Stakes Are High For Regeneron s Eylea HD As Genentech s Vabysmo Continues To Gain Momentum, Prompting Doctors To Weigh Their Options Between Two Indus menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Exton, Pennsylvania, Nov. 01, 2023 (GLOBE NEWSWIRE) As U.S. ophthalmologists increasingly embrace a wider array of treatment options, the landscape of the diabetic macular edema (DME) market has begun
Genentech announced the FDA had approved faricimab-svoa (Vabysmo) for retinal vein occlusion on October 26, 2023, which marks the third ophthalmic indication for the bispecific antibody.